CD163 and systemic sclerosis: These “hybrid” monocytes (CD14+CD80+CD86+TLR4+CD163+CD204+CD206+cells) are significantly more expressed in the peripheral blood of SSc-patients than HSs and are associated with clinically overt SSc-ILD (20).